USAQOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
QHSLab, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.32+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $7.38M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.1020 (+46.79%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
QHSLab, Inc. grew revenue 24.6% to $3.02M over the twelve months to Jun 30, 2026. Operating income fell 48.9% to $82.62K, moving the operating margin from 6.7% to 2.7%.
Revenue
$3.02M
+24.6% vs. a year earlier
Operating income
$82.62K
-48.9% vs. a year earlier
EPS, diluted
-$0.03
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $7.38M
- P/E ratio
- –
- Price to sales
- 2.45
- Price to book
- 4.74
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $3.02M
- Net income
- -$390.73K
- EPS, diluted
- -$0.03
- Book value per share
- $0.07
- Diluted shares
- 23M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$3.02M+24.6% YoY
Gross profit
$2.04M+27.2% YoY
Operating income
$82.62K-48.9% YoY
Net income
-$390.73K
EPS, diluted
-$0.03
Reported periodTrailing twelve months